Survival of AIDS patients using two case definitions, Rio de Janeiro, Brazil, 1986-2003

AIDS

Volumn 19, Issue SUPPL. 4, 2005, Pages

  Campos, Dayse Pereira ^a,d   Ribeiro, Sayonara Rocha ^c   Grinsztejn, Beatriz ^a   Veloso, Valdiléa G ^a   Valente, Joaquim Gonçalves ^b   Bastos, Francisco Inácio ^b   Morgado, Mariza Gonçalves ^b   Gadelha, Angela Jourdan ^b  

^a Funda??o Oswaldo Cruz   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Municipal Health Department of Rio de Janeiro   (Brazil)

^d NONE   (Brazil)

Author keywords

AIDS; Brazil; Case definition; Highly active antiretroviral therapy; Survival

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAZIL; CELL COUNT; COHORT ANALYSIS; CONFIDENCE INTERVAL; DEATH; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; SURVIVAL;

EID: 27944508760     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000191486.92285.1c     Document Type: Article

References (19)

1. Fonseca LA, Reingold AL, Casseb JR, Brígidio LF, Duarte AJ. AIDS incidence and survival in a hospital-based cohort of asymptomatic HIV seropositive patients in São Paulo, Brazil. Int J Epidemiol 1999; 28:1156-1160.
2. Guerreiro MF, Kerr-Pontes LRS, Mota RS, Marcondes CF Jr, Tavora FF, Caminha I. Survival of adult AIDS patients in a reference hospital of a metropolitan area in Brazil. Revista de Saúde Pública 2002; 36:278-284.
3. Marins JR, Jamal LF, Chen SY, Barros MB, Hudes ES, Barbosa AA, et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS 2003; 17:1675-1682.
4. Lee ML, Karon MJ, Selik R, Neal JJ, Fleming PL. Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States 1984-1997. JAMA 2001; 285:1308-1315.
5. Brazil. Ministry of Health in Brazil. National DST/AIDS program. AIDS cases definition criteria in adults and children. Manuals Series, 60. 2004.
6. US Department of Health Human Services, Centers for Disease Control and Prevention (CDC). Impact of expanded AIDS surveillance case definition on AIDS case reporting. MMWR 1993; 16:308-311.
7. Brazil. Ministry of Health in Brazil. National DST/AIDS program. Brazilian AIDS profile and government goals for epidemic control. 2003; p. 3.
8. UNAIDS. The Joint United Nations Programs on HIV/AIDS. Abstracts of the UNAIDS 3rd Meeting of the Latin America and Caribbean Epidemiological Network. 1999; pp. 12-14.
9. Kleinbaum DG. Survival Analysis - A self-learning text. Statistics in the health sciences. New York: Springer-Verlag. 1997.
10. Cox DR. Regression models and life-tables. J Roy Statistical Soc Series B 1972; 34:187-202.
11. Dore GJ, Li Y, McDonald A, Ree H, Kaldor JM. Impact of highly active antiretroviral therapy on individual AIDS - defining illness incidence and survival in Australia. J Acquir Immune Defic Syndr 2002; 29:388-395.
12. 9 cells/l. Ann Intern Med 2003; 139:810-816.
13. CASCADE. Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE. Br HIV Assoc HIV Med 2000; 1:224-231.
14. Santoro-Lopes G, Harrison LH, Moulton LH, Lima LA, Pinho AM, Hofer C, Schechter M. Gender and survival after AIDS in Rio de Janeiro Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:403-407.
15. Detels R, Muñoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, et al. Effectiveness of potent anti-retroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS cohort study investigators. JAMA 1998; 280:1497-1503.
16. Brockington A, Scott GR. Trends in survival of HIV infected patients attending the Department of Genito-Urinary Medicine. Royal Infirmary of Edinburgh. Scot Med J 1997; 42:114-115.
17. Dworkin MS, Hanson DL, Navin TR. The adult and adolescent spectrum HIV survival of patients with AIDS, after diagnosis of Pneumocystis carinii pneumonia, in the United States. J Infect Dis 2001; 183:1409-1412.
18. Amundsen EJ, Fekjaer H. Progression to AIDS slowed even more after the first two years with highly active antiretroviral therapy. Scand J Public Health 2003; 31:312-318.
19. Li Y, McDonald AM, Dore GJ, Kaldor JM. Improving survival following AIDS in Australia. National HIV Surveillance Committee. AIDS 2000; 14:2349-2354.